Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid

This publication has 293 references indexed in Scilit:

• No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls
  Annals of Neurology, 2000
• Nongenotoxic (epigenetic) carcinogens: Pesticides as an example. A critical review
  Teratogenesis, Carcinogenesis, and Mutagenesis, 2000
• High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease
  Biochemical and Biophysical Research Communications, 1999
• Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
• Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype
  Annals of Neurology, 1995
• Inhibition of l-glutamate uptake into synaptic vesicles
  Neuroscience Letters, 1992
• Neuropathological stageing of Alzheimer-related changes
  Acta Neuropathologica, 1991
• Elevated circulating tumor necrosis factor levels in Alzheimer's disease
  Neuroscience Letters, 1991
• Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
  Biochemical and Biophysical Research Communications, 1984